Skip to main content
. 2007 Apr 20;73(11):3575–3580. doi: 10.1128/AEM.00011-07

FIG. 1.

FIG. 1.

Proposed biosynthetic route to saframycin MX1. (i) SAM methylation. (ii) NRPS-catalyzed formation of a tetrapeptide intermediate. This intermediate is folded by a Pictet-Spengler or Bischler-Napieralski condensation into a saframycin precursor. Further methylation and oxidation lead to the formation of saframycin MX1. This study defines intermediate 4′-O-methyl-l-dopa as the first committed intermediate; previously, the timing of C- versus O-methylation was unclear.